Ted Buchan & CO Pfizer Inc Transaction History

Ted Buchan & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Sep 06, 2024	SELL	$26.13 - $33.94 $231,720 - $300,979	-8,868 Closed	0 $0
Q3 2023 Sep 06, 2024	SELL	$32.09 - $37.51 $72,844 - $85,147	-2,270 Reduced 20.38%	8,868 $294 Million
Q2 2023 Sep 06, 2024	SELL	$36.12 - $41.79 $198,985 - $230,221	-5,509 Reduced 33.09%	11,138 $409 Million
Q1 2023 Sep 06, 2024	BUY	$39.39 - $51.28 $80,710 - $105,072	2,049 Added 14.04%	16,647 $679 Million
Q4 2022 Sep 06, 2024	BUY	$41.75 - $54.5 $609,466 - $795,591	14,598 New	14,598 $748 Million

3,267

3.73B

74.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ted Buchan & CO, based on Form 13F filings with the SEC.

Stay updated on Ted Buchan & CO with notifications on news.